scispace - formally typeset
M

Mijin Yun

Researcher at Yonsei University

Publications -  139
Citations -  4679

Mijin Yun is an academic researcher from Yonsei University. The author has contributed to research in topics: Positron emission tomography & Fluorodeoxyglucose. The author has an hindex of 35, co-authored 129 publications receiving 4240 citations. Previous affiliations of Mijin Yun include Maastricht University & Hospital of the University of Pennsylvania.

Papers
More filters
Journal Article

18F-FDG PET in Characterizing Adrenal Lesions Detected on CT or MRI

TL;DR: Because FDG PET has the additional advantage of evaluating the primary lesions as well as metastases, it could be cost-effective and the modality of choice for the characterization of adrenal lesions, especially in patients with malignancy.
Journal ArticleDOI

F-18 FDG uptake in the large arteries: a new observation.

TL;DR: Vascular FDG uptake is present in 50% of the patients examined for this study, with an increased prevalence in older patients, which might be explained by smooth muscle metabolism in the media, subendothelial smooth muscle proliferation from senescence, and the presence of macrophages within the atherosclerotic plaque.
Journal ArticleDOI

Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET.

TL;DR: It is concluded that measuring the SUV by using the CT size to correct for resolution and partial volume effects offers potential value in differentiating malignant from benign lesions in this population of patients.
Journal ArticleDOI

18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors.

TL;DR: The positive correlation of arterial FDG uptake with the atherogenic risk factors suggested a promising role for FDG-PET imaging in the diagnosis of atherosclerosis and follow-up after treatment intervention.
Journal ArticleDOI

Diagnosis and staging of primary ovarian cancer: Correlation between PET/CT, Doppler US, and CT or MRI

TL;DR: PET/CT is superior to pelvis US, abdomino-pelvic CT, and pelvic MRI for diagnosis of malignant ovarian tumors and is useful in revealing metastatic ovarian cancer and co-existing malignant tumors.